The chemical structure Enzyme-linked immunosorbent assay analysis with a kinetic assay and enzyme-linked immunosorbent assay inhibition confirmed the antigenic heterogeneity of H. influenzae lipid A. Thin-layer chromatography demonstrated that the 3D2 epitope is associated with a chloroform-soluble lipid moiety in the lipid A. Fluorescent antibody analysis of H. influenzae indicated that the epitope is on the cell surface. The monoclonal gntibody was not bactericidal for strain 3524, and it did not inhibit the bactericidal action of normal human serum against the same strain. These studies demonstrate that the lipid As of H. influenzae are antigenicaily heterogeneous.
Since 1963, the concept that the lipid A component of the lipopolysaccharide (LPS) of gram-negative bacteria represents a heterogeneous group of structures has gained acceptance (21) . Chang and Nowotny have shown that the lipid A pbrtions of the LPS structure are not identical in structure or function (4) . Other investigators demonstrated that fractionation of a single lipid A preparation resulted in the identification of eight fractions which had a range of antigen expression (3, 16, 17) . Five of these fractions could react with anti-lipid A antiserum, whereas the three with the greatest number of esterfied fatty acids failed to react. Thus it would appear that antigenic variability among lipid A's should be anticipated as more extensive studies specifically with monoclonal antibodies are developed.
We have had the opportunity to study a number of nontypable Haemophilus influenzae LPS preparations with a monioclonal antibody developed to a nontypable H. influenzae strain, 3524. This monoclonal antibody, designated 3D2, has been shown to react with a determinant present on the lipid A portion of the LPS. The investigations presented in this paper indicate that the determinant recognized by this monoclonal antibody is not present on the lipid A of all H. influenzae strains. Studies of other Haemophilus species and a diverse group of gram-negative and gram-positive bacteria indicate that this antigenic determinant is highly specific for H. influenzae.
MATERIALS AND METHODS
Bacteria. Prototype strains of nontypable H. influenzae representative of the eight sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) types described by Murphy et al. (19) were obtained from our own collection. The identity of each isolated strain had been * Corresponding author.
confirmed previously as H. influenzae by colonial morphology and growth requirement for X and V factors. Counterimmunoelectrophoresis (20) had been used to determine serotype with antiserum and reference strains obtained from the Centers for Disease Control, Atlanta, Ga. Nontypable H. influenzae 3524 was isolated from the sputum of a patient with chronic bronchitis at the Erie County Medical Center, Buffalo, N.Y. It has been demonstrated to be piliated (2) and has been shown to have a type 2 outer membrane protein pattern on SDS-PAGE (19 (ii) Fusion of donor spleen cells to the NS-1 nonsecreting clone of the P3x63Ag8 BALB/c plasmacytoma. To achieve fusion of the donor spleen cells to the NS-1 (nonsecreting variant of the immunoglobulin Gl [IgGl] BALB/c plasmacytoma P3x63Ag8) plasmacytoma cells (obtained fromn the Salk Institute for Biology under National Cancer Institute contract NO1-CB-23886), 35% polyethylene glycol was used in a modification of the procedure of Kennett (13). Briefly, 107 spleen cells were combined with 106 NS-1 cells in MEM with serum. The cells were centrifuged at 170 x g for 10 min at 25°C. All of the supernatant was removed, and the pellet was tapped to loosen. A 0.2-ml sample of 35% polyethylene glycol 1000 (Sigma Chemical Co., St. Louis, Mo.) in MEM without serum was added, the mixture was stirred lightly and left at 25°C, and timing was started for 8 min. The cells were pelleted at 500 x g for 3 min. At the end of the original 8 min, 5 ml of MEM with serum was added and gently pipetted once to resuspend the pellet. The mixture was centrifuged at 250 x g for 5 min at room temperature. All of the supernatant was removed. A 5-ml sample of complete growth medium (MEM with high glucose and 20% bovine fetal serum) was added to resuspend the pellet. The mixture was transferred to a 25 ml Erlenmeyer flask containing the appropriate amount of complete MEM to obtain 3 x i05 plasmacytoma cells per ml. The cells were stirred lightly and distributed in 0.05-ml samples into microtiter wells. At 24 h after the polyethylene glycol fusion, 0.05 ml of hypoxanthine-aminopterin-thymidine medium was added to each well. The microtiter plates were placed in a tissue culture incubator at 85% humidity under 5% carbon dioxide. Fresh hypoxanthine-aminopterin-thymidine medium was added at day 7, and plates were checked for macroscopic plaques after day 10. The supernatant from all wells was tested for the presence of antibody by using an enzyme-linked immunosorbent assay (ELISA) system in which 10 jig of strain 3524 outer membranes per ml was coated to the microtiter plates. The peroxidase-conjugated rabbit anti-murine IgG or protein A was used to detect the presence of antibody binding to the outer membranes. Wells which contained hybridomas producing antibody to outer membranes were retested against microtiter plates coated with strain 3524 LPS to identify those clones producing antibody to LPS. These clones were propagated by subsequent transfer to larger tissue culture wells. Large quantities of antibody were produced in tissue culture and by the intraperitoneal injection of 105 cells from the LPS antibody-producing clone into 2,6,10,14-tetramethylpentadecane (pristane)-primed BALB/c mice. The resulting ascitic fluid was harvested in 3 to 4 weeks, and the ascitic fluid was tested for specificity of the respective antibody. The IgG3 antibody was removed from the ascitic fluid by passage over a protein A-Sepharose column. Similar peritoneal tumors were established by using NS-1 cells. The resultant fluid was used as a control.
The monoclonal antibody produced in tissue culture fluid was purified by affinity chromatography over a murine IgG affinity column. This antibody was used to confirm the results obtained with the ascitic fluid-derived antibody.
Preparation of LPS, lipid A and outer membranes. H. influenzae LPS was prepared by a modification of the phenol-water method of Perry et al. (22) . Lipid A was prepared by heating 20 mg of the LPS preparation in 1.0 M acetic acid in a boiling water bath for 1 h. The lipid A precipitate was removed by centrifugation at 15,000 x g for 30 min. The precipitate was lyophilized after it was washed twice by suspension in distilled water followed by centrifugation. The acetic acid and wash supernatants were pooled and lyophilized. This contained the saccharide portion of the LPS. The lipid A fraction was further fractionated by the method of Chang and Nowotny (4) . This involves sequential extractions with ethyl acetate and chloroform. Three fractions are recovered, an ethyl acetate-insoluble fraction, a chloroform-soluble fraction, and a chloroform-insoluble fraction. Outer membranes were prepared by the method of Murphy et al. (19) .
Thin-layer chromatography. Thin-layer chromatography was performed by a modification of the method of Banerji and Alving with a chloroform-acetone (85:15) solvent system with silica gel 60 plates (EM Laboratories, Elmsford, N.Y.) (3) . Lipid spots were identified on the dried chromatograms by using iodine vapors and confirmed with bromothymol blue spray, phosphate-containing residues were identified with molybdenum blue reagent, carbohydrates were identified with orcinol (0.25% orcinol in 75% sulfuric acid), and amino acid-containing compounds were identified with ninhydrin spray (0.3% in butanol-acetic acid) (26) .
Western blot analysis. Analysis of the specificity of the 3D2 monoclonal antibody was performed by Western blot methodology (14) with a Trans-blot apparatus (Bio-Rad Laboratories, Richmond, Calif). Briefly, samples were subjected to SDS-PAGE by the Laemmli method (15) . At the end of this electrophoresis, the gel was removed and placed in the Trans-blot apparatus with a 10-by 20-cm sheet of nitrocellulose over 1. Immunodot assay. A modified dot assay utilizing nitrocellulose paper was described previously (9) . In this assay, the sample to be screened for the presence of antigen is solubilized in SDS-PAGE sample buffer at 1 mg/ml, and 10 ,LI is placed in a 1.5-cm square on the paper. The sample is allowed to dry, and the sheet is then treated in a fashion identical to that described above for the Western blot technique.
Kinetic ELISA. The quantitative, single-tube, kineticdependent ELISA (herein referred to as the kinetic ELISA) uses enzyme rate kinetics to quantitate bound enzyme and assay ligand (either antigen or antibody). This assay was performed by the method of Tsang and co-workers (27 Immunodiffusion studies were performed on 10-fold-concentrated tissue culture fluid to determine the immunoglobulin class of the monoclonal antibody. For these studies, antisera specific for murine IgM, IgGl, IgG2a, IgG2b, and IgG3 were obtained from Bionetics, Kensington, Md. RESULTS
Utilizing splenocytes from a BALB/c mouse immunized with nontypable H. influenzae 3524, a series of hybridomas were developed by fusion of NS-1 plasmacytoma cells. Among the clones producing antibody to the H. influenzae strain, one designated 3D2 was found by ELISA screening to be producing antibody to LPS isolated from this strain. This monoclonal antibody was determined by immunodiffusion to be of the IgG3 variety.
Analysis of the specificity of 3D2. To determine the nature of the antigenic specificity of 3D2, Western blot and immunodot blot analyses were utilized. Figure 1A (Fig. 2A) .
To obtain additional information about the nature of the epitope recognized by 3D2 and to assure that the monoclonal is not recognizing saccharides which might be residual contaminants or on unhydrolyzed LPS in the lipid A, strain 3524 lipid A was subjected to sequential ethyl acetatechloroform extraction. Monoclonal 3D2 immunodot assay of the three fractions obtained by this extraction indicated that strong reactivity was present in the chloroform-soluble fraction (Fig. 2B, lanes 2 and 3) . Definite but weaker reactivity occurred in the chloroform-insoluble fraction. The ethyl acetate fraction did not react with 3D2 (Fig. 2B, lane 1) . Analysis of these fractions with iodine vapors and chromatography sprays indicated that the chloroform-soluble and -insoluble fractions stained with iodine vapor and bromothymol blue, whereas the ethyl acetate fraction failed to stain with either reagent. Ninhydrin stained the chloroform-insoluble fraction strongly and the chloroform-soluble fraction weakly; the ethyl acetate fraction failed to stain with ninhydrin. Molybdenum reagent stained the chloroformsoluble fraction strongly and the chloroform-insoluble stained weakly; the ethyl acetate fraction did not stain, Orcinol analysis indicated that the ethyl acetate and the chloroform-insoluble fractions stained weakly, whereas the chloroform-soluble fraction failed to stain. This would indicate that the chloroform-soluble fraction, which monoclonal 3D2 recognized, was primarily lipid and contained both amino compounds and phosphates. It appeared to be free of significant amounts of unsubstituted carbohydrates. Thinlayer chromatographic analysis of this fraction on silica gel in the chloroform-acetone solvent system (85:15) resulted in three spots: one at the origin, a second with an Rf value of 0.38, and the third with an Rf value of 0.85. These spots were identified with iodine vapors and scraped from the plate and eluted with chloroform from the silica. Immunodot assay of this extract material indicated that 3D2 recognized the epitope in the eluate from each spot (Fig. 2C) were performed. Kinetic ELISA analysis (Fig. 3) been shown to be associated with the toxic activity ascribed to LPS. Lipid A is not a single macromolecular structure, but appears to be a complex array of a variety of lipids (3, 11, 12, 16, 18) . Variation in the lipid A of the same strain has been demonstrated (16) . This has been shown to be based on variation of the composition of the ester-linked fatty acids and substitution of the phosphate groups (16) . The chemical structure of lipid A from enteric bacteria has been elaborated and has been shown to consist of a (1'-6)-linked diglucosamine oligosaccharide which contains two phosphate groups (8) . This backbone structure is substituted by a variety of hydrophilic and hydrophobic substances, including amide-linked and ester-linked fatty acids. Lipid A also appears to have a highly conserved antigenic structure among a wide range of gram-negative bacteria. Immunological studies of lipid A from enteric bacteria have demonstrated a high degree of cross-reactivity which extends to the non-Enterobacteriaceae (6, 16). The fundamental antigenic component which will react with polyclonal antisera to lipid A has been shown to be the diglucosamine backbone substituted with a single amide-linked myristic acid (6 (5) studied LPS from H. influenzae types a through f. Chemical analysis was completed only on the type b serotype and indicated that it contained 30% total carbohydrate and 29.3% lipid. Analysis of the sugars in the carbohydrate revealed glucose, galactose, glucosamine, and heptose, whereas the lipid component contained lauric, myristic, and palmitic acid. Biologic studies with these LPS preparations indicated that the preparations were toxic for mice and could be used to stimulate murine spleen cells. This latter effect could be blocked by polymyxin and was considered secondary to the lipid A component. Immunological studies with immunodiffusion and hemagglutination analysis suggested immunological heterogeneity among H. influenzae strains and indicated the presence of at least three antigenically distinct factors associated with these LPS. The source of these antigenic differences was considered to be the oligosaccharide portion of the LPS moiety; however, chemical analysis indicated that the carbohydrates were composed of identical sugars. It was assumed the differences were based on differences in sequence or the fine structure of the sugars. Recently, Insana demonstrated electrophoretic heterogeneity of H. influenzae by using microextracts of LPS on SDS-PAGE gels and silver staining (10); 50 strains were studied, and 33 could be classified into 11 subtypes.
Nontypable strains appeared to demonstrate less LPS electrophoretic variation than that seen among type b strains. The basis for this heterogeneity has not been elucidated.
In this study, we have demonstrated that there are at least two antigenically distinct lipid A moieties among typable and nontypable H. influenzae strains. The epitope responsible for this differentiation is a lipid moiety which can be recovered in the chloroform-soluble portion of the lipid A. Analysis of non-Haemophilus species indicates that the epitope was absent among the strains studied. The epitope does not appear to be a bactericidal target but appears to be surface exposed based on fluorescent antibody analysis. These results are similar to those obtained by Mattsby-Baltzer and Kaliser, who showed the limited ability to demonstrate surface exposure of lipid A determinants on Enterobacteriaceae with polyclonal antisera (18) . ELISA inhibition and kinetic ELISA analysis indicated that 3D2 recognizes the determinant on free lipid A and lipid A bound to polystyrene plastic surfaces. The ELISA inhibition studies would also indicate that this epitope may be present in low concentrations on strains which lack the determinant in Western blot analysis.
These studies demonstrate the antigenic heterogeneity of the lipid A of H. influenzae. Future efforts will be directed at determining the association of this determinant with the virulence of H. influenzae and in determining the precise nature of the structure responsible for the epitope recognized by monoclonal antibody 3D2.
